Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
HONG KONG, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Coinweb (https://coinweb.io), a unique interoperable layer 2 platform, connecting Bitcoin, Ethereum and another 7 blockchains, will launch its Mainnet...
-
Wilmington, Delaware, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Electric Vehicle Battery Housing Market by Vehicle Type (Passenger Cars and Commercial...
-
Wilmington, Delaware, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Deferasirox Market by Product Type (90 mg, 125 mg, 250 mg, 360 mg and Others),...
-
Wilmington, Delaware, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Dental Market by Product Type (Dental Consumables and Dental Equipment), and End User...
-
Wilmington, Delaware, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Depilatories Products Market by Product Type (Creams, Wax Strips, Razors and Others),...
-
Wilmington,Delaware, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Smart Electric Vehicle Market by Vehicle Type (Passenger Cars and Commercial Vehicles),...
-
Wilmington, Delaware, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Cognitive Electronic Warfare System Market by Capability (Electronic Attack, Electronic...
-
Alvotech er einn tveggja aðila sem vitað er að hafi byrjað klíníska rannsókn á sjúklingum fyrir fyrirhugaða líftæknilyfjahliðstæðu við Entyvio (vedolizumab)Á síðustu tólf mánuðum, fram til loka...
-
Alvotech is one of two companies known to have initiated a global or multi-country confirmatory patient study for a biosimilar candidate to Entyvio®Sales of Entyvio (vedolizumab) were about $5.4...
-
Alvotech is one of two companies known to have initiated a global or multi-country confirmatory patient study for a biosimilar candidate to Entyvio®Sales of Entyvio (vedolizumab) were about $5.4...